BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18710399)

  • 1. Disposition of eslicarbazepine acetate in the mouse after oral administration.
    Alves G; Figueiredo I; Castel-Branco M; Lourenço N; Falcão A; Caramona M; Soares-da-Silva P
    Fundam Clin Pharmacol; 2008 Oct; 22(5):529-36. PubMed ID: 18710399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection.
    Alves G; Figueiredo I; Castel-Branco M; Loureiro A; Falcão A; Caramona M
    Anal Chim Acta; 2007 Jul; 596(1):132-40. PubMed ID: 17616250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5-carboxamide derivatives in mouse plasma and brain tissue: eslicarbazepine acetate, carbamazepine and main metabolites.
    Fortuna A; Bicker J; Alves G; Falcão A; Soares-da-Silva P
    J Sep Sci; 2011 Jun; 34(12):1391-401. PubMed ID: 21557472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker.
    Falcão A; Maia J; Almeida L; Mazur D; Gellert M; Soares-da-Silva P
    Biopharm Drug Dispos; 2007 Jul; 28(5):249-56. PubMed ID: 17443646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma.
    Alves G; Figueiredo I; Castel-Branco M; Loureiro A; Fortuna A; Falcão A; Caramona M
    Biomed Chromatogr; 2007 Nov; 21(11):1127-34. PubMed ID: 17594694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and drug interactions of eslicarbazepine acetate.
    Bialer M; Soares-da-Silva P
    Epilepsia; 2012 Jun; 53(6):935-46. PubMed ID: 22612290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chiral liquid chromatography method for the simultaneous determination of oxcarbazepine, eslicarbazepine, R-licarbazepine and other new chemical derivatives BIA 2-024, BIA 2-059 and BIA 2-265, in mouse plasma and brain.
    Fortuna A; Alves G; Almeida A; Lopes B; Falcão A; Soares-da-Silva P
    Biomed Chromatogr; 2012 Mar; 26(3):384-92. PubMed ID: 21780155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective disposition of S- and R-licarbazepine in mice.
    Alves G; Figueiredo I; Falcão A; Castel-Branco M; Caramona M; Soares-Da-Silva P
    Chirality; 2008 Jun; 20(6):796-804. PubMed ID: 18306292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy.
    Kim TH; Reid CA; Petrou S
    Epilepsia; 2015 Jan; 56(1):e6-9. PubMed ID: 25489632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
    Perucca E; Elger C; Halász P; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsy Res; 2011 Sep; 96(1-2):132-9. PubMed ID: 21680153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
    Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Jan; 54(1):108-16. PubMed ID: 22812691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective assay for therapeutic drug monitoring of eslicarbazepine acetate: no interference with carbamazepine and its metabolites.
    Alves G; Fortuna A; Sousa J; Direito R; Almeida A; Rocha M; Falcão A; Soares-da-Silva P
    Ther Drug Monit; 2010 Aug; 32(4):512-6. PubMed ID: 20592643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an enantioselective liquid-chromatography/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma.
    Loureiro AI; Fernandes-Lopes C; Wright LC; Soares-da-Silva P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2611-8. PubMed ID: 21816689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma.
    Fortuna A; Sousa J; Alves G; Falcão A; Soares-da-Silva P
    Anal Bioanal Chem; 2010 Jun; 397(4):1605-15. PubMed ID: 20401721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.
    Zhang C; Zuo Z; Kwan P; Baum L
    Epilepsia; 2011 Oct; 52(10):1894-904. PubMed ID: 21692796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy.
    Almeida L; Minciu I; Nunes T; Butoianu N; Falcão A; Magureanu SA; Soares-da-Silva P
    J Clin Pharmacol; 2008 Aug; 48(8):966-77. PubMed ID: 18508949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans.
    Almeida L; Soares-da-Silva P
    J Clin Pharmacol; 2004 Aug; 44(8):906-18. PubMed ID: 15286095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.
    Maia J; Almeida L; Falcão A; Soares E; Mota F; Potgieter MA; Potgieter JH; Soares-da-Silva P
    Int J Clin Pharmacol Ther; 2008 Mar; 46(3):119-30. PubMed ID: 18397682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.